<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tangri N</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>PHS HHS</funding><pagination>667-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4402378</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Intravenous iron use in hemodialysis patients has greatly increased over the last decade, despite limited studies on the safety of iron.&lt;h4>Methods&lt;/h4>We studied the association of receipt of intravenous iron with hospitalizations in an incident cohort of hemodialysis patients. We examined 9544 patients from Dialysis Clinic, Inc. (DCI). We ascertained intravenous iron use from DCI electronic medical record and USRDS data files, and hospitalizations through Medicare claims. We examined the association between iron exposure accumulated over 1-, 3- or 6-month time windows and incident hospitalizations in the follow-up period using marginal structural models accounting for time-dependent confounders. We performed sensitivity analyses including recurrent events models for mu</pubmed_abstract><journal>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</journal><pubmed_title>Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.</pubmed_title><pmcid>PMC4402378</pmcid><funding_grant_id>K23 DK095949</funding_grant_id><funding_grant_id>K23DK083514</funding_grant_id><funding_grant_id>K23 DK097184</funding_grant_id><funding_grant_id>K23 DK083514</funding_grant_id><funding_grant_id>UL1 TR001079</funding_grant_id><funding_grant_id>K23DK095949</funding_grant_id><funding_grant_id>UL1 TR001117</funding_grant_id><funding_grant_id>HHSA290200500341I</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Jaar BG</pubmed_authors><pubmed_authors>Navaneethan S</pubmed_authors><pubmed_authors>Scheel P</pubmed_authors><pubmed_authors>Ebony Boulware L</pubmed_authors><pubmed_authors>Schold J</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Miskulin DC</pubmed_authors><pubmed_authors>Zager P</pubmed_authors><pubmed_authors>Ephraim P</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Michels W</pubmed_authors><pubmed_authors>St Peter W</pubmed_authors><pubmed_authors>Bandeen-Roche K</pubmed_authors><pubmed_authors>Heubner B</pubmed_authors><pubmed_authors>DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Crews DC</pubmed_authors><pubmed_authors>Tangri N</pubmed_authors><pubmed_authors>Scialla J</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors><pubmed_authors>Sozio S</pubmed_authors><pubmed_authors>Nally J</pubmed_authors><pubmed_authors>Miskulin D</pubmed_authors><pubmed_authors>Jaar B</pubmed_authors><pubmed_authors>Konig V</pubmed_authors><pubmed_authors>Arrigain S</pubmed_authors><pubmed_authors>Shafi T</pubmed_authors><pubmed_authors>Crews D</pubmed_authors><pubmed_authors>Meyer K</pubmed_authors><pubmed_authors>Sozio SM</pubmed_authors><pubmed_authors>Boulware LE</pubmed_authors><pubmed_authors>Michels WM</pubmed_authors><pubmed_authors>Scialla JJ</pubmed_authors><pubmed_authors>Cook C</pubmed_authors><pubmed_authors>Ephraim PL</pubmed_authors><pubmed_authors>Collins A</pubmed_authors><pubmed_authors>Coresh J</pubmed_authors><pubmed_authors>McDermott A</pubmed_authors><pubmed_authors>Luly J</pubmed_authors><pubmed_authors>Wu A</pubmed_authors><pubmed_authors>Foley R</pubmed_authors><pubmed_authors>Jolly S</pubmed_authors><pubmed_authors>Herzog C</pubmed_authors><pubmed_authors>Gilbertson D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.</name><description>&lt;h4>Background&lt;/h4>Intravenous iron use in hemodialysis patients has greatly increased over the last decade, despite limited studies on the safety of iron.&lt;h4>Methods&lt;/h4>We studied the association of receipt of intravenous iron with hospitalizations in an incident cohort of hemodialysis patients. We examined 9544 patients from Dialysis Clinic, Inc. (DCI). We ascertained intravenous iron use from DCI electronic medical record and USRDS data files, and hospitalizations through Medicare claims. We examined the association between iron exposure accumulated over 1-, 3- or 6-month time windows and incident hospitalizations in the follow-up period using marginal structural models accounting for time-dependent confounders. We performed sensitivity analyses including recurrent events models for mu</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-04-19T00:48:05.812Z</modification><creation>2019-03-27T01:50:07Z</creation></dates><accession>S-EPMC4402378</accession><cross_references><pubmed>25366328</pubmed><doi>10.1093/ndt/gfu349</doi></cross_references></HashMap>